Spinning the ‘RARE Wheel’

Event Summary

‘RARE’ is becoming the new common as these life-threatening diseases are affecting larger populations, with 6.5 to 10 cases in every 10,000 people as defined by the WHO. Last decade witnessed the researchers raring to spin the RARE wheel.

Numbers suggest that this area is a promising ‘mining opportunity’

But, to mine out a viable product, it is imperative to find answers to tough questions that some of the major pharmaceutical companies seem to be grappling with; most important being – “how to ensure optimal ROI from investments in orphan drugs while navigating through a complex maze of regulatory and pricing challenges?”